Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Outer capsid protein VP4 is a key structural protein of Rotavirus A that forms the prominent spikes projecting from the outer layer of the triple-shelled virion. VP4 is a non-glycosylated protein that must be enzymatically cleaved by trypsin-like proteases into two functional subunits, VP8* (the N-terminal head domain) and VP5* (the C-terminal body and foot domain), to prime the virus for infectivity. VP8* mediates initial attachment to host cell surface glycans or histo-blood group antigens, while VP5* acts as a membrane-permeating protein that facilitates viral penetration and release into the host cytoplasm. VP4 is a major determinant of viral host range restriction, tissue tropism, and virulence, and it defines the P (protease-sensitive) serotype of the virus.
As a primary target of neutralizing antibodies, VP4 is a critical antigen in the design of both live-attenuated vaccines (such as Rotarix and RotaTeq) and novel recombinant subunit vaccines (such as truncated VP4* candidates). Neutralizing antibodies targeting VP4 work by blocking viral attachment or preventing the essential conformational rearrangements of the spike required for membrane penetration. Although there are currently no approved small-molecule drugs directly targeting VP4, it remains a highly attractive target for therapeutic antibodies and entry inhibitors aimed at preventing or treating severe rotavirus-induced gastroenteritis in infants and young children.
Neutralization of viral infectivity by blocking viral attachment to host cell receptors or preventing the conformational transition of the spike protein required for membrane penetration.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Outer capsid protein VP4 (VP4).